August 9th, 2011
Will ISCHEMIA Tell Us More than COURAGE? PART II: Banking on Eight Years of Equipoise
Judith Hochman, L. David Hillis, MD and Richard A. Lange, MD, MBA
(Continued from Part I: Aiming to Beat Bias with Blinding) On August 1, 2011, the Langone Medical Center at New York University announced that the National Heart, Lung, and Blood Institute has provided a grant to fund the ISCHEMIA study of an invasive strategy versus optimal medical management in patients with stable coronary artery disease and […]
August 8th, 2011
Will ISCHEMIA Tell Us More Than COURAGE? Part I: Aiming to Beat Bias with Blinding
Judith Hochman, L. David Hillis, MD and Richard A. Lange, MD, MBA
On August 1, 2011, New York University announced that the National Heart, Lung, and Blood Institute would fund the ISCHEMIA study of an invasive strategy versus optimal medical management in patients with stable coronary artery disease and moderate-to-severe ischemia. We welcome the members of the study Executive Committee, chaired by Dr. Judith Hochman, to answer […]
August 1st, 2011
Going Beyond COURAGE: NHLBI Funds the ISCHEMIA Study
Larry Husten, PHD
The NHLBI has awarded an $84 million grant to fund the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA). The trial will randomize 8,000 patients with stable ischemic heart disease and moderate-to-severe ischemia. Two different treatment strategies will be compared: An invasive strategy, consisting of early routine cardiac catheterization followed by revascularization […]
May 3rd, 2011
CABG Takes the Brunt of Decline in Revascularization Procedures
Larry Husten, PHD
In recent years, the overall revascularization rate in the U.S. has declined only slightly, but CABG rates have taken the brunt of the change, while PCI rates have remained relatively stable, according to a new study by Andrew Epstein and colleagues published in JAMA. The researchers found that from 2001-2002 to 2007-2008: The annual rate of revascularization […]
NEJM Journal Watch — Recent Cardiology Articles- To Lower Stroke Risk in Patients Undergoing Atrial Fibrillation Ablation, Is a Device or a Medication Better?
- Intensive vs. Standard Blood Pressure Lowering in Patients with Diabetes
- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy